Short time personalised dialysis: good results in spite of high levels of small and middle molecules.
After almost two years of experience with 43 patients we believe that a short (3 X 4, 3 X 3 hr/week) personalised dialysis is a safe treatment that allows a high survival rate and a good rehabilitation of patients. Pre-dialysis levels of small and middle molecules, the latter only calculated, did not correlate with 5 typical uraemic parameters. Some patients, who formerly experienced standard dialysis, are now equally well or better, without evidence of increasing toxicity, in spite of their higher pre-dialysis levels of small and especially of middle molecules.
D000328:Adult; D001002:Anuria / Q000628:therapy; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy*; D008875:Middle Aged; D008970:Molecular Weight; D006435:Renal Dialysis / Q000379:methods*; D013997:Time Factors